新型冠状病毒肺炎疫情下慢性阻塞性肺疾病患者的中医药防控措施

Prevention and control measures of traditional Chinese medicine in patients with chronic obstructive pulmonary disease under the COVID-19 epidemic

新型冠状病毒肺炎作为烈性传染病,其病情凶险。慢性阻塞性肺疾病是常见的慢性气道疾病,属中医“肺胀”范畴,其病位在肺,与脾肾关系密切,患者素体多痰湿,易感冒,此时疫情肆虐,固护正气为关键。中医药在此次疫情的防治工作中,疗效显著,尤其是“治未病”的理论,为慢性阻塞性肺疾病患者预防新型冠状病毒感染提供了更优化的诊疗方案。全国老中医药专家朱莹教授在参与武汉救治新冠患者后,认为“脾胃虚弱”为慢性阻塞性肺疾病患者的基本病理状态,顾护脾胃,可以发挥“未病先防”“既病防变”的重要作用。本文主要总结慢性阻塞性肺疾病患者的中医药防控措施。

As a severe infectious disease,COVID-19 has a dangerous condition.Chronic obstructive pulmonary disease is a common chronic airway disease,it belongs to the category of"lung distention"in traditional Chinese medicine,the disease is located in the lung and is closely related to the spleen and kidney,patients have many phlegm and dampness and are easy to get cold,at this time,the epidemic is raging,to reinforce healthy qi is the most important.In the prevention and treatment of the epidemic,traditional Chinese medicine has a significant effect,in particular,the theory of"preventive treatment of disease"provides a more optimal diagnosis and treatment plan for patients with COPD to prevent COVID-19 infection.After participating in the treatment of patients with COVID-19 in Wuhan city,professor Zhu Ying,a national expert in traditional Chinese medicine,believed that"weakness of the spleen and stomach"is the basic pathological state of COPD patients,so protect the spleen and stomach can play an important role of"preventive treatment of disease"and"preventing the development of the occured disease".This article mainly summarizes the traditional Chinese medicine prevention and control measures of COPD patients.